Intellipharmaceutics International has announced that the US Food and Drug Administration (FDA) has granted final approval of the company's dexmethylphenidate hydrochloride extended-release capsules for the 15 and 30mg strengths. ...
Tags: Focalin XR, Medicine
US-based specialty pharmaceutical firm Par Pharmaceutical has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for clonidine hydrochloride (HCl) extended-release (ER) ...
Tags: Par Pharmaceutical, Medicine
Texas-based private-equity firm TPG Capital is said to be considering signing an agreement to acquire Envision Pharmaceutical Holdings, an Ohio-based pharmacy-benefits manager (PBM), for an undisclosed sum. Sources familiar with the ...
Tags: Envision Pharmaceutical, TPG
The US Food and Drug Administration (FDA) has approved Par Pharmaceutical Companies' abbreviated new drug application (ANDA) for fluvoxamine maleate 100mg and 150mg extended-release (ER) capsules. Fluvoxamine maleate ER capsules are ...
Tags: FDA, Drug, fluvoxamine maleate ER
Depomed's lawsuits against Watson Laboratories and Par Pharmaceutical in relation to Abbreviated New Drug Applications (ANDAs) for Gralise (gabapentin) have been dismissed. The company said that both the companies no longer sought ...
Tags: Depomed, Watson Laboratories, Par Pharmaceutical, lawsuit
Watson Pharmaceuticals has received the US Federal Trade Commission (FTC) approval for its acquisition of the Actavis group of companies. The approval is the result of Watson's agreement to a proposed consent order to divest certain ...
TPG and Par Pharmaceutical have announced the completion of Par's purchase by certain TPG affiliates. According to the merger agreement, Par's stockholders are eligible to earn $50.00 in cash, without interest, less any applicable ...
Horizon Pharma has filed a patent infringement lawsuit in the US District Court for the District of Delaware against Par Pharmaceutical. The suit is related to an abbreviated new drug application that Par filed with the FDA to market ...
Tags: Patent, Lawsuit, drug application